[unable to retrieve full-text content]A provision buried in the fiscal bill passed earlier this month gives Amgen, the world?s largest biotechnology firm, more time to sell a lucrative kidney dialysis drug without price restraints.



Source: http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html?partner=rss&emc=rss
Chicago teachers strike yahoo finance september 11 2001 september 11 2001 dr oz serena williams blake lively
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.